Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

BACKGROUND: One of the major challenges in diagnosing dementia with Lewy bodies (DLB) is the common co-morbid presence of amyloid pathology. To understand the putative role of altered amyloid-β (Aβ) metabolism in dementia with DLB, we analyzed levels of different cerebrospinal fluid (CSF) Aβ peptide...

Descripción completa

Detalles Bibliográficos
Autores principales: van Steenoven, Inger, van der Flier, Wiesje M., Scheltens, Philip, Teunissen, Charlotte E., Lemstra, Afina W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788069/
https://www.ncbi.nlm.nih.gov/pubmed/31601267
http://dx.doi.org/10.1186/s13195-019-0537-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788069/
https://www.ncbi.nlm.nih.gov/pubmed/31601267
http://dx.doi.org/10.1186/s13195-019-0537-5

Ejemplares similares